PE(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
|
Basic information |
| Metabolite name | PE(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) |
 | HMDB0009012 |
 |
C00350 |
 |
9546798 |
| Synonyms | NA |
| No. of studies | 3 |
|
Basic information |
| Metabolite name | PE(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) |
| HMDB0009012 |
|
C00350 |
|
9546798 |
| Synonyms | NA |
| No. of studies | 3 |
|
Relationship between PE(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) and depression (count: 3) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M1041 | Type2 | pilocarpine + mitochondrial transplantation group vs. pilocarpine group | Hippocampus | C57BL/6J mouse | Down |
| Study M572 | Type1 | major antenatal depression group vs. control group | Plasma | Human | Up |
| Study M609 | Type1 | LPS group vs. control group | Hippocampus | Sprague-Dawley rat | Up |
| Study M609 | Type2 | LPS + NBP group vs. LPS group | Hippocampus | Sprague-Dawley rat | Up |